Please wait while we take you to your selected region.
Semax is a synthetic peptide derived from adrenocorticotropic hormone (ACTH) fragments. It has been studied for potential nootropic and neuroprotective effects, including possible increases in brain-derived neurotrophic factor (BDNF).
Functional MRI research suggests that Semax may increase activity in the brain's default mode network, which is involved in resting attention, social awareness, and monitoring the environment. This may help the brain shift more easily from a resting state to a focused state. Increased activity in this network is also associated with stronger brain connections, memory, problem-solving, and creativity, although these effects have not been directly confirmed for Semax.
Semax is used in Russia in research and treatment settings involving cerebral hypoxia, stroke, and traumatic brain injury. Animal studies suggest that it may influence genes involved in blood vessel function, neuron survival, mitochondrial activity, and the formation of new blood vessels. These effects may help protect brain cells and improve the supply of oxygen and nutrients.
Research in stroke rehabilitation has reported that Semax may support faster functional recovery and improved motor performance. It may also increase levels of BDNF, a natural brain protein involved in learning, memory, and neuroplasticity.
Studies in healthy rats suggest that a single intranasal dose of Semax can affect gene activity in the hippocampus and frontal cortex. These areas are important for memory, learning, concentration, planning, and decision-making. Changes in genes related to nerve growth factor (NGF) and BDNF may help explain Semax's possible effects on brain function.
Semax has been studied for its possible ability to support learning and memory, especially in cases involving neurological impairment. Research on ACTH, the natural peptide from which Semax is derived, suggests that it may help protect cognitive function during conditions such as seizures. These findings have led researchers to investigate Semax for possible nootropic and neuroprotective effects.
Animal research suggests that Semax may influence BDNF, a protein involved in brain cell growth, learning, and mood regulation. Because BDNF activity is also linked to the effects of antidepressants, researchers are exploring whether Semax could help improve understanding of depression and support future treatment approaches. However, more research is needed to confirm its effectiveness and safety for depression.